메뉴 건너뛰기
Atencion Primaria
Volumn 43, Issue 7, 2011, Pages 386-387
Detection of cardiovascular risk factors in patients with psychosis;Detección de factores de riesgo cardiovascular en pacientes con psicosis
Author keywords

[No Author keywords available]
Indexed keywords

CARDIOVASCULAR RISK; HUMAN; LETTER; MENTAL PATIENT; PSYCHOSIS;
EID: 79959851392     PISSN: 02126567     EISSN: 15781275     Source Type: Journal    
DOI: 10.1016/j.aprim.2010.04.021     Document Type: Letter
Times cited : (3)
References (6)
  • 1
    • 50649111874 scopus 로고    scopus 로고
    • A comparison of schizophrenia outpatients treated with antipsychotics with and without metabolic syndrome: Findings from the CLAMORS study
    • CLAMORS Study Collaborative Group
    • C. Arango, J. Bobes, P. Aranda, R. Carmena, M. García- García, J. Rejas CLAMORS Study Collaborative Group A comparison of schizophrenia outpatients treated with antipsychotics with and without metabolic syndrome: findings from the CLAMORS study Schizophr Res. 104 2008 1 12
    • (2008) Schizophr Res. , vol.104 , pp. 1-12
    • Arango, C.1    Bobes, J.2    Aranda, P.3    Carmena, R.4    García-García, M.5    Rejas, J.6
  • 2
    • 39049166498 scopus 로고    scopus 로고
    • Monitoring and management of metabolic risk factors in outpatients taking antipsychotic drugs: A controlled study
    • A. Jennex, and D.M. Gardner Monitoring and management of metabolic risk factors in outpatients taking antipsychotic drugs: a controlled study Can J Psychiatry. 53 2008 34 42 (Pubitemid 351235839)
    • (2008) Canadian Journal of Psychiatry , vol.53 , Issue.1 , pp. 34-42
    • Jennex, A.1    Gardner, D.M.2
  • 3
    • 34447316519 scopus 로고    scopus 로고
    • Minimising metabolic and cardiovascular risk in schizophrenia: Diabetes, obesity and dyslipidaemia
    • A.H. Barnett, P. Mackin, I. Chaudhry, A. Farooqi, R. Gadsby, and A. Heald Minimising metabolic and cardiovascular risk in schizophrenia: diabetes, obesity and dyslipidaemia J Psychopharmacol. 21 2007 357
    • (2007) J Psychopharmacol. , vol.21 , pp. 357
    • Barnett, A.H.1    MacKin, P.2    Chaudhry, I.3    Farooqi, A.4    Gadsby, R.5    Heald, A.6
  • 4
    • 35648978587 scopus 로고    scopus 로고
    • A UK audit of screening for the metabolic side effects of antipsychotics in community patients
    • DOI 10.1093/schbul/sbm038
    • T.R. Barnes, C. Paton, M.R. Cavanagh, E. Hancock, and D.M. Taylor UK Prescribing Observatory for Mental Health. A UK audit of screening for the metabolic side effects of antipsychotics in community patients Schizophr Bull. 33 2007 1397 1403 (Pubitemid 350022774)
    • (2007) Schizophrenia Bulletin , vol.33 , Issue.6 , pp. 1397-1403
    • Barnes, T.R.E.1    Paton, C.2    Cavanagh, M.-R.3    Hancock, E.4    Taylor, D.M.5
  • 5
    • 27744502054 scopus 로고    scopus 로고
    • Prevalence of the metabolic syndrome in patients with schizophrenia: Baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III
    • DOI 10.1016/j.schres.2005.07.014, PII S0920996405003105
    • J.P. McEvoy, J.M. Meyer, D.C. Goff, H.A. Nasrallah, S.M. Davis, and L. Sullivan Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III Schizophr Res. 80 2005 19 32 (Pubitemid 41587460)
    • (2005) Schizophrenia Research , vol.80 , Issue.1 , pp. 19-32
    • McEvoy, J.P.1    Meyer, J.M.2    Goff, D.C.3    Nasrallah, H.A.4    Davis, S.M.5    Sullivan, L.6    Meltzer, H.Y.7    Hsiao, J.8    Scott Stroup, T.9    Lieberman, J.A.10
  • 6
    • 20444392049 scopus 로고    scopus 로고
    • Prevalencia de síndrome metabólico en la población de un centro de atención primaria urbano
    • M.M. Coca, P. Hernanz, M. Vega, and C. Suárez Prevalencia de síndrome metabólico en la población de un centro de atención primaria urbano Aten. Primaria. 35 2005 436 437
    • (2005) Aten. Primaria. , vol.35 , pp. 436-437
    • Coca, M.M.1    Hernanz, P.2    Vega, M.3    Suárez, C.4

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.